< Back to situations

[PERSON]

Maria Kaparelou

Featured in 6 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

314 clusters · 1159 sources · last updated

Latest: GLP-1 medications and weight management strategies

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. Cardiovascular benefits rema

[ACTIVE] [HEALTH] [US] [GR] [IT]

Advances and challenges in mRNA and immunotherapy trials

11 clusters · 25 sources · last updated

Latest: Immunotherapy advancements show promise in treating colorectal and melanoma cancers

Cancer immunotherapy is evolving through personalized mRNA vaccines and cellular therapies. Recent breakthroughs include a platform generating T-cells from hematopoietic stem cells, which offers a ready-to-use alternativ

[QUIET] [HEALTH] [US] [GR]

FDA approvals for ESR1-mutated breast cancer

2 clusters · 4 sources · last updated

Latest: FDA approvals advance treatment for ESR1-mutated breast cancer

The U.S. Food & Drug Administration has expanded treatment options for hormone receptor-positive/HER2-negative metastatic breast cancer by approving therapies targeting ESR1 mutations. In September 2026, the FDA granted

[QUIET] [HEALTH] [GR]

Research into cellular senescence and aging

2 clusters · 11 sources · last updated

Latest: Scientific research and practical strategies address cellular aging and senior well-being

Medical researchers are investigating cellular senescence as a primary therapeutic target for age-related diseases. Experts from the Alexandra Hospital and the National and Kapodistrian University of Athens have identifi